Inhibition of platelet aggregation by drugs.
D000241:Adenosine / Q000494:pharmacology*; D000244:Adenosine Diphosphate / Q000008:administration & dosage / Q000494:pharmacology; D000818:Animals; D001241:Aspirin / Q000494:pharmacology*; D001772:Blood Cell Count; D001777:Blood Coagulation / Q000187:drug effects; D001792:Blood Platelets; D003094:Collagen / Q000494:pharmacology; D003720:Densitometry; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D006801:Humans; D066298:In Vitro Techniques; D007275:Injections, Intravenous; D008722:Methods; D009130:Muscle, Smooth / Q000187:drug effects; D010208:Papaverine / Q000009:adverse effects / Q000494:pharmacology*; D010653:Phenylbutazone / Q000494:pharmacology*; D010973:Platelet Adhesiveness / Q000187:drug effects*; D011817:Rabbits; D013696:Temperature; D013917:Thrombin / Q000494:pharmacology; D014665:Vasodilator Agents / Q000009:adverse effects
D014665:Vasodilator Agents; D000244:Adenosine Diphosphate; D003094:Collagen; D010208:Papaverine; D013917:Thrombin; D010653:Phenylbutazone; D000241:Adenosine; D001241:Aspirin